This summer, a group of talented students received a jump start on a career in the biopharmaceutical industry during the NIIMBL eXperience.

Building on the success of previous years, NIIMBL held its third eXperience from June 14 – 25, 2021. This program gives African American/Black, Latinx and Native American college freshmen and sophomores an...

The United States Pharmacopeia (USP), the U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) and The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), have announced a research collaboration to assess analytical methods and develop standards for adeno-associated virus (AAV), an...

The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has made two awards totaling $153 million to the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). The awards were announced today by U.S. Secretary of Commerce Gina Raimondo at the NIIMBL annual meeting in Washington, D.C.

NIIMBL...

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce funding for 10 new projects in technology, workforce development, and their Global Health Fund initiative, resulting from the Institute’s Project Call 4.1, and with a total value of approximately $4.6M.

“Since our inception five years ago, we...

The National Institute for Manufacturing Biopharmaceuticals (NIIMBL) announced 17 students selected for their 2021 NIIMBL eXperience Program. The NIIMBL eXperience is offered to African American/Black, Latinx, and Native American college freshman and sophomores students from Historically Black Colleges and Universities (HBCUs) and NIIMBL member...